Evidence map›Paper›PMID 24982089›Full record

ArticleAntimicrobial agents and chemotherapy2014

Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection.

Yuichiro Miura, Matthew S Payne, Jeffrey A Keelan, Andres Noe, Sean Carter, Rory Watts, Owen B Spiller, Alan H Jobe, Suhas G Kallapur, Masatoshi Saito and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. PlacingChildren (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Chronic Intra-UterineFrontiers in immunology · 2020
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. A new antibiotic regimen treats and prevents intra-amniotic inflammation/infection in patients with preterm PROM.The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2016
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 4 countries.

Yuichiro MiuraSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Matthew S PayneSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Jeffrey A KeelanSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Andres NoeSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Sean CarterSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Rory WattsSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Owen B SpillerDepartment of Child Health, School of Medicine, Cardiff University, Cardiff, United Kingdom.
Alan H JobeDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Centre, University of Cincinnati, School of Medicine, Cincinnati, Ohio, USA.
Suhas G KallapurDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Centre, University of Cincinnati, School of Medicine, Cincinnati, Ohio, USA.
Masatoshi SaitoDivision of Perinatal Medicine, Tohoku University Hospital, Sendai, Japan.
Sarah J StockMRC Centre for Reproductive Health, University of Edinburgh, United Kingdom.
John P NewnhamSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia.
Matthew W KempSchool of Women's and Infants' Health, The University of Western Australia, Perth, Western Australia, Australia matthew.kemp@uwa.edu.au.
University of Western Australia · AUUniversity of Cincinnati · USCardiff University · GBMRC Centre for Reproductive Health · GBTohoku University Hospital · JP

Funding

Medical Research Council G1002033
6 · The paper itself

Abstract

Intrauterine infection with Ureaplasma spp. is strongly associated with preterm birth and adverse neonatal outcomes. We assessed whether combined intraamniotic (IA) and maternal intravenous (IV) treatment with one of two candidate antibiotics, azithromycin (AZ) or solithromycin (SOLI), would eradicate intrauterine Ureaplasma parvum infection in a sheep model of pregnancy. Sheep with singleton pregnancies received an IA injection of U. parvum serovar 3 at 85 days of gestational age (GA). At 120 days of GA, animals (n=5 to 8/group) received one of the following treatments: (i) maternal IV SOLI with a single IA injection of vehicle (IV SOLI only); (ii) maternal IV SOLI with a single IA injection of SOLI (IV+IA SOLI); (iii) maternal IV AZ and a single IA injection of vehicle (IV AZ only); (iv) maternal IV AZ and a single IA injection of AZ (IV+IA AZ); or (v) maternal IV and single IA injection of vehicle (control). Lambs were surgically delivered at 125 days of GA. Treatment efficacies were assessed by U. parvum culture, quantitative PCR, enzyme-linked immunosorbent assay, and histopathology. Amniotic fluid (AF) from all control animals contained culturable U. parvum. AF, lung, and chorioamnion from all AZ- or SOLI-treated animals (IV only or IV plus IA) were negative for culturable U. parvum. Relative to the results for the control, the levels of expression of interleukin 1β (IL-1β), IL-6, IL-8, and monocyte chemoattractant protein 2 (MCP-2) in fetal skin were significantly decreased in the IV SOLI-only group, the MCP-1 protein concentration in the amniotic fluid was significantly increased in the IV+IA SOLI group, and there was no significant difference in the histological inflammation scoring of lung or chorioamnion among the five groups. In the present study, treatment with either AZ or SOLI (IV only or IV+IA) effectively eradicated macrolide-sensitive U. parvum from the AF. There was no discernible difference in antibiotic therapy efficacy between IV-only and IV+IA treatment regimens relative to the results for the control.

Indexed as

Administration, IntravenousAmniotic FluidAnimalsAnti-Bacterial AgentsAzithromycinChemokine CCL2Chemokine CCL8FemaleFetusInterleukinsLungMacrolidesPneumoniaPregnancyPregnancy Complications, InfectiousSheepAnti-Bacterial AgentsAzithromycinChemokine CCL2Chemokine CCL8InterleukinsMacrolidessolithromycinTriazoles

Identifiers

PMID24982089
PMCPMC4135857
OpenAlexW2109914470

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.